Acadia Pharmaceuticals
ACAD
ACAD
155 hedge funds and large institutions have $2.08B invested in Acadia Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $2.18B → $2.08B (-$102M)
11% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 54
Holders
155
Holding in Top 10
11
Calls
$360M
Puts
$21.9M
Top Buyers
| 1 | +$65.7M | |
| 2 | +$23.3M | |
| 3 | +$22.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$21.6M | |
| 3 | -$17.9M | |
| 4 |
Alkeon Capital Management
New York
|
-$17.5M |
| 5 |
PA
Perceptive Advisors
New York
|
-$16.8M |